Cedars-Sinai Health Ventures

Regard offers an AI-driven platform that enhances hospital operations by assisting in diagnoses, reducing coding queries, and streamlining patient care processes. It benefits various stakeholders within the healthcare system.

Health Note is an AI-powered health data management platform that collects patient information through voice and digital intake tools, automatically formats it into clinical notes, and integrates with electronic medical records to streamline documentation and pre-visit workflows. The platform is frictionless and platform-agnostic, enabling patients to participate in their care without apps or portals and reducing administrative burden for clinicians while improving care team efficiency. Founded in 2018 and based in San Francisco, Health Note aims to simplify clinical documentation and EMR integration.

Founded in 2019, NotiSphere develops a platform enabling medical device suppliers to communicate product recalls electronically. It facilitates real-time communication between suppliers and healthcare providers, reducing recall cycle times, exposed patients, and effort required by providers.

Diligent Robotics develops hospital service robots and related AI software to assist clinical and nursing staff with logistical tasks, enabling more time for direct patient care. Its flagship robot, Moxi, operates in hospital environments to handle routine duties and collaborate with humans, supported by AI-based software that enables safe interaction and adaptation to human workflows. Founded in 2017 and based in Austin, Texas, the company seeks to improve patient satisfaction, quality of care, and safety by augmenting healthcare teams with robotic assistance.

Pulse Charter Connect specializes in streamlining organ transportation logistics. It operates a digital platform that automates and optimizes both air and ground transportation processes, replacing manual methods. This enables medical professionals to concentrate on their critical tasks, saving time, reducing costs, and enhancing the likelihood of successful organ transplants.